Publikationstyp: Beitrag in wissenschaftlicher Zeitschrift
Art der Begutachtung: Peer review (Publikation)
Titel: Frequency, reactivity and evolution of human leukocyte antigen and human platelet antigen antibodies in the setting of hematopoietic cell transplantation
Autor/-in: Bräutigam, Michelle
Volken, Thomas
Plattner, Alexandra
Passweg, Jakob R.
Halter, Jörg P.
Drexler, Beatrice
Heim, Dominik
Schaub, Stefan
Buser, Andreas S.
Infanti, Laura
Holbro, Andreas
et. al: No
DOI: 10.1016/j.transci.2021.103301
Erschienen in: Transfusion and Apheresis Science
Band(Heft): 61
Heft: 2
Seite(n): 103301
Erscheinungsdatum: 29-Okt-2021
Verlag / Hrsg. Institution: Elsevier
ISSN: 1473-0502
Sprache: Englisch
Schlagwörter: HLA antibody; HPA antibody; Hematopoietic cell transplantation; Matched related; Donor derived
Fachgebiet (DDC): 617: Chirurgie
Zusammenfassung: Background and objectives: Antibodies (Ab) against HLA and HPA antigens play an important role in HCT. In this prospective study we evaluated prevalence and kinetics of HLA- and HPA-Ab after HCT, including a possible donor-recipient transfer and their clinical relevance in respect to platelet transfusion refractoriness (PTR). Materials and methods: Patients were consecutively recruited. Ab were determined by microbead assay technique and a mean fluorescence intensity cut-off of 1,000. Results: At baseline, 21 donors (42%) and 27 patients (54%) had HLA-Ab with a mean panel reactivity (cPRA) of 34.9 ± 29.4% and 46.1 ± 36.5%, respectively. We observed a significant higher number of HLA-Ab specificities in female donors and patients and a predominance of HLA-class I Ab. At day 0 we detected an increase of HLA-Ab (from 526 to 673) and cPRA (55.2 ± 31.9%). Thirty-six patients (72%) developed new HLA-Ab, mainly 3 weeks after HCT. In 7 patients an HLA-Ab with the same specificity as detected in the corresponding donor emerged, suggesting a possible transfer from the donor to the recipient. Overall, MFI showed a high variation. Type and number of transfusions were not associated with number and intensity of HLA-Ab (ρ: -0.05 – 0.02). Number of HLA-Ab, cPRA and intensity were not associated with PTR, which occurred in 9 patients (18%) and none had bleeding WHO > 2. Conclusions: Although a considerable number of patients have and develop HLA-Ab before and early after HCT, we found no association with PTR and bleeding and management should be individualized.
Volltext Version: Publizierte Version
Lizenz (gemäss Verlagsvertrag): Lizenz gemäss Verlagsvertrag
Departement: Gesundheit
Organisationseinheit: Institut für Public Health (IPH)
Enthalten in den Sammlungen:Publikationen Gesundheit

Dateien zu dieser Ressource:
Es gibt keine Dateien zu dieser Ressource.
Zur Langanzeige

Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.